Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Shanghai Pharmaceuticals Holding Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Pharmaceuticals Holding Co Ltd (601607) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.56 Billion ≈ $227.99 Million USD) by net assets (CN¥89.62 Billion ≈ $13.11 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)

Cash flow conversion efficiency of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. This chart illustrates how Shanghai Pharmaceuticals Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 601607 live share price for real-time trading data and today's change.

Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Conversion Ratio Explained

Shanghai Pharmaceuticals Holding Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Pharmaceuticals Holding Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Pharmaceuticals Holding Co Ltd ranked by their cash flow conversion efficiency. Also see Shanghai Pharmaceuticals Holding Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hyundai Heavy Industries Holdings Co Ltd KO:267250	0.075x
NINGBO SHANSHAN GDR/A F:OJ8	N/A
HELLENIC TELEC.ORG.ADR1/2 F:OTES	0.168x
Maha Properti Indonesia Tbk PT JK:MPRO	-0.003x
Gaztransport & Technigaz SAS PA:GTT	0.372x
Open Text Corp TO:OTEX	0.079x
Arcellx Inc NASDAQ:ACLX	-0.145x
Amdocs Ltd NASDAQ:DOX	0.064x

Annual Cash Flow Conversion Efficiency for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. Review Shanghai Pharmaceuticals Holding Co Ltd (601607) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥89.79 Billion ≈ $13.14 Billion	CN¥6.15 Billion ≈ $900.55 Million	0.069x	-1.50%
2024-12-31	CN¥83.74 Billion ≈ $12.25 Billion	CN¥5.83 Billion ≈ $852.71 Million	0.070x	+6.84%
2023-12-31	CN¥80.33 Billion ≈ $11.75 Billion	CN¥5.23 Billion ≈ $765.54 Million	0.065x	+7.10%
2022-12-31	CN¥78.00 Billion ≈ $11.41 Billion	CN¥4.74 Billion ≈ $694.10 Million	0.061x	-29.03%
2021-12-31	CN¥59.07 Billion ≈ $8.64 Billion	CN¥5.06 Billion ≈ $740.63 Million	0.086x	-31.47%
2020-12-31	CN¥54.74 Billion ≈ $8.01 Billion	CN¥6.84 Billion ≈ $1.00 Billion	0.125x	+2.54%
2019-12-31	CN¥49.39 Billion ≈ $7.23 Billion	CN¥6.02 Billion ≈ $881.26 Million	0.122x	+80.61%
2018-12-31	CN¥46.43 Billion ≈ $6.79 Billion	CN¥3.14 Billion ≈ $458.77 Million	0.068x	+1.13%
2017-12-31	CN¥39.68 Billion ≈ $5.81 Billion	CN¥2.65 Billion ≈ $387.60 Million	0.067x	+26.32%
2016-12-31	CN¥36.83 Billion ≈ $5.39 Billion	CN¥1.95 Billion ≈ $284.86 Million	0.053x	+32.43%
2015-12-31	CN¥33.81 Billion ≈ $4.95 Billion	CN¥1.35 Billion ≈ $197.42 Million	0.040x	-7.08%
2014-12-31	CN¥31.10 Billion ≈ $4.55 Billion	CN¥1.34 Billion ≈ $195.45 Million	0.043x	+27.95%
2013-12-31	CN¥29.00 Billion ≈ $4.24 Billion	CN¥973.45 Million ≈ $142.45 Million	0.034x	-19.20%
2012-12-31	CN¥27.70 Billion ≈ $4.05 Billion	CN¥1.15 Billion ≈ $168.39 Million	0.042x	-39.10%
2011-12-31	CN¥25.98 Billion ≈ $3.80 Billion	CN¥1.77 Billion ≈ $259.36 Million	0.068x	-51.92%
2010-12-31	CN¥11.88 Billion ≈ $1.74 Billion	CN¥1.69 Billion ≈ $246.73 Million	0.142x	-50.39%
2009-12-31	CN¥2.32 Billion ≈ $339.84 Million	CN¥664.13 Million ≈ $97.18 Million	0.286x	+109.19%
2008-12-31	CN¥2.09 Billion ≈ $305.80 Million	CN¥285.68 Million ≈ $41.80 Million	0.137x	-45.25%
2007-12-31	CN¥1.96 Billion ≈ $286.56 Million	CN¥488.94 Million ≈ $71.55 Million	0.250x	-11.50%
2006-12-31	CN¥2.07 Billion ≈ $302.45 Million	CN¥583.11 Million ≈ $85.33 Million	0.282x	+675.17%
2005-12-31	CN¥2.01 Billion ≈ $293.52 Million	CN¥73.00 Million ≈ $10.68 Million	0.036x	+21.65%
2004-12-31	CN¥2.06 Billion ≈ $301.60 Million	CN¥61.66 Million ≈ $9.02 Million	0.030x	+13043.04%
2003-12-31	CN¥2.13 Billion ≈ $311.31 Million	CN¥484.27K ≈ $70.86K	0.000x	-99.55%
2002-12-31	CN¥2.00 Billion ≈ $292.60 Million	CN¥100.84 Million ≈ $14.76 Million	0.050x	+39.50%
2001-12-31	CN¥1.82 Billion ≈ $266.06 Million	CN¥65.73 Million ≈ $9.62 Million	0.036x	-75.64%
2000-12-31	CN¥985.30 Million ≈ $144.18 Million	CN¥146.22 Million ≈ $21.40 Million	0.148x	-23.41%
1999-12-31	CN¥849.92 Million ≈ $124.37 Million	CN¥164.67 Million ≈ $24.10 Million	0.194x	+148.82%
1998-12-31	CN¥713.42 Million ≈ $104.40 Million	CN¥-283.14 Million ≈ $-41.43 Million	-0.397x	--

About Shanghai Pharmaceuticals Holding Co Ltd

SHG:601607 China Medical Distribution

Market Cap

$6.74 Billion

CN¥46.08 Billion CNY

Market Cap Rank

#2846 Global

#300 in China

Share Price

CN¥16.52

Change (1 day)

+0.55%

52-Week Range

CN¥15.29 - CN¥18.41

All Time High

CN¥25.03